SCHEMBL8904064

SCHEMBL8904064

CCCCCC(CCCc1ccccc1)C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.60
PTGES O14684 4/20 0.54
ALOX5 P09917 4/20 0.54
PPARG P37231 4/20 0.54
CNR2 P34972 1/20 0.51
MMP2 P08253 3/20 0.50
MMP3 P08254 3/20 0.50
MMP1 P03956 1/20 0.50
MMP9 P14780 1/20 0.50
MMP8 P22894 1/20 0.50
CPB2 Q96IY4 1/20 0.49
HPGD P15428 1/20 0.49
FOLH1 Q04609 1/20 0.49
ALDH1A1 P00352 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28807882 0.98 GRIK1 (0.59) GRIK1PTGESALOX5PPARGCNR2
SCHEMBL8904462 0.98 GRIK1 (0.59) GRIK1PTGESALOX5PPARGCNR2
SCHEMBL30839920 0.95 GRIK1 (0.55) GRIK1PTGESALOX5PPARGCPB2
SCHEMBL355603 0.95 GRIK1 (0.55) GRIK1PTGESALOX5PPARGCPB2
SCHEMBL10869949 0.95 GRIK1 (0.55) GRIK1PTGESALOX5PPARGCPB2
SCHEMBL11305180 0.95 GRIK1 (0.55) GRIK1PTGESALOX5PPARGCPB2
SCHEMBL5385323 0.95 GRIK1 (0.55) GRIK1PTGESALOX5PPARGCPB2
SCHEMBL1131425 0.95 GRIK1 (0.62) GRIK1PTGESALOX5PPARGCNR2
SCHEMBL8904812 0.93 MMP2 (0.56) GRIK1PTGESALOX5PPARGCNR2
SCHEMBL8905261 0.92 MMP2 (0.55) GRIK1PTGESALOX5PPARGCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114206866-A Prostaglandin E2Receptor 4 antagonists and uses thereof 泰昂治疗公司 2022-03-18 CN disclosed
US-5597848-A PLATELET AGGREGATION INHIBITORS, ANTITHROMBOTIC AGENTS, ANTIASTHMATIC AGENTS, ANTIALLERGIC AGENTS HOKURIKU SEIYAKU CO., LTD. (JP) 1997-01-28 US disclosed